Skip to the page

Data / Drug companies / Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC: 273 products in the FDA NDC directory, labeler code 65162

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Amneal Pharmaceuticals LLC (labeler code 65162) lists 273 products in the FDA National Drug Code Directory, covering 115 finished drugs by generic name. By type: 260 prescription drugs, 13 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 12, 2025.

The request: Watch Amneal Pharmaceuticals LLC (FDA labeler code 65162): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
65162
Products in commercial distribution
273
Packages
714
Finished drugs by generic name
115
Prescription products
260
Over the counter products
13
Controlled substance products
Schedule II 13, Schedule III 4, Schedule IV 10, Schedule V 1
Flagged as original packager
251 of 251 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
1
Earliest marketing start
November 25, 1998
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)26998.5%
Other unapproved drugs41.5%

Products by type

TypeProductsShare
Prescription drugs26095.2%
Over the counter drugs134.8%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Estradiol1153
Warfarin910
Aripiprazole749
Lisdexamfetamine63
Cetirizine65
Temozolomide612
Lamotrigine651
Levetiracetam587
Ibuprofen5190
Valsartan and hydrochlorothiazide521
Lurasidone hydrochloride528
Oxycodone56
Milnacipran hcl41
Temazepam428
Valsartan438
Gabapentin491
Alprazolam437
Bethanechol chloride46
Benazepril hydrochloride424
Paliperidone419
Memantine hydrochloride436
Irbesartan327
Montelukast317
Rivastigmine311
Citalopram331
Cinacalcet318
Telmisartan329
Spironolactone345
Felbamate311
Escitalopram oxalate322
Pitavastatin33
Naproxen358
Niacin313
Oxybutynin chloride345
Paricalcitol313
Promethazine hydrochloride349
Hydroxyzine32
Lidocaine3216
Flecainide acetate313
Itraconazole214
Memantine27
Chlorthalidone242
Demeclocycline23
Dextromethorphan polistirex227
Metformin hydrochloride279
Sulfamethoxazole and trimethoprim248
Diclofenac sodium and misoprostol211
Calcitriol223
Acebutolol hydrochloride26
Fesoterodine fumarate212
Benzonatate242
Primidone223
Guanfacine233
Acyclovir270
Guaifenesin2123
Entecavir215
Cyclobenzaprine hydrochloride261
Prasugrel210
Alosetron hydrochloride26
Buprenorphine and naloxone222
Progesterone239
Guaifenesin and dextromethorphan hbr226
Phenazopyridine213
Salsalate22
Pantoprazole225
Divalproex sodium248
Lubiprostone220
Fosphenytoin sodium28
Meclizine hydrochloride241
Diclofenac212
Sodium oxybate16
Oxycodone and acetaminophen132
Meclizine110
Aspirin and extended-release dipyridamole14
Promethazine and phenylephrine11
Nitrofurantoin128
Olopatadine hydrochloride135
Acetaminophen and codeine16
Sevelamer carbonate135
Colchicine134
Phenytoin sodium124
Indomethacin136
Risperidone143
Lorazepam138
Escitalopram134
Quinine11
Sucralfate oral16
Folic acid134
Nitrofurantoin monohydrate/macrocrystals11
Metaxalone138
Raloxifene hydrochloride116
Ritonavir18
Dutasteride114
Tobramycin141
Oxcarbazepine146
Azelastine14
Voriconazole134
Sildenafil153
Mesalamine141
Etonogestrel and ethinyl estradiol16

Dosage forms

Dosage formProductsShare
Tablet10036.6%
Capsule3613.2%
Tablet, film coated3011%
Tablet, extended release238.4%
Solution165.9%
Patch, extended release103.7%
Suspension72.6%
Tablet, film coated, extended release72.6%
Tablet, delayed release62.2%
Tablet, coated62.2%
Patch51.8%
Capsule, extended release51.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sodium Oxybate65162-065SolutionGeneric drugs (ANDA)September 12, 2025
Mesalamine65162-360Tablet, delayed releaseGeneric drugs (ANDA)February 19, 2025
Pitavastatin65162-031Tablet, film coatedGeneric drugs (ANDA)August 21, 2024
Pitavastatin65162-030Tablet, film coatedGeneric drugs (ANDA)August 21, 2024
Pitavastatin65162-029Tablet, film coatedGeneric drugs (ANDA)August 21, 2024
Dapsone65162-339GelGeneric drugs (ANDA)October 24, 2023
Lisdexamfetamine Dimesylate65162-028CapsuleGeneric drugs (ANDA)August 28, 2023
Lisdexamfetamine Dimesylate65162-027CapsuleGeneric drugs (ANDA)August 28, 2023
Lisdexamfetamine Dimesylate65162-026CapsuleGeneric drugs (ANDA)August 28, 2023
Lisdexamfetamine Dimesylate65162-025CapsuleGeneric drugs (ANDA)August 28, 2023
Lisdexamfetamine Dimesylate65162-024CapsuleGeneric drugs (ANDA)August 28, 2023
Lisdexamfetamine Dimesylate65162-023CapsuleGeneric drugs (ANDA)August 28, 2023
Valsartan and Hydrochlorothiazide65162-849Tablet, film coatedGeneric drugs (ANDA)August 14, 2023
Valsartan and Hydrochlorothiazide65162-848Tablet, film coatedGeneric drugs (ANDA)August 14, 2023
Valsartan and Hydrochlorothiazide65162-847Tablet, film coatedGeneric drugs (ANDA)August 14, 2023
Valsartan and Hydrochlorothiazide65162-846Tablet, film coatedGeneric drugs (ANDA)August 14, 2023
Valsartan and Hydrochlorothiazide65162-845Tablet, film coatedGeneric drugs (ANDA)August 14, 2023
Fesoterodine Fumarate65162-370Tablet, extended releaseGeneric drugs (ANDA)January 6, 2023
Fesoterodine Fumarate65162-369Tablet, extended releaseGeneric drugs (ANDA)January 6, 2023
Lurasidone Hydrochloride65162-882Tablet, coatedGeneric drugs (ANDA)January 2, 2023
Lurasidone Hydrochloride65162-881Tablet, coatedGeneric drugs (ANDA)January 2, 2023
Lurasidone Hydrochloride65162-880Tablet, coatedGeneric drugs (ANDA)January 2, 2023
Lurasidone Hydrochloride65162-879Tablet, coatedGeneric drugs (ANDA)January 2, 2023
Lurasidone Hydrochloride65162-082Tablet, coatedGeneric drugs (ANDA)January 2, 2023
Diclofenac Sodium65162-683SolutionGeneric drugs (ANDA)August 23, 2022

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.